1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Medacta Group SA
  6. Financials
    MOVE   CH0468525222

MEDACTA GROUP SA

(MOVE)
  Report
Delayed Swiss Exchange  -  11:30 2022-07-01 am EDT
91.40 CHF   +0.33%
06/23Medacta Announces First Lumbar Fusion Procedure with NextAR Augmented Reality Surgical Platform in Australia
EQ
05/24MEDACTA : Company Presentation
PU
05/19Medacta Group announces the results of today's Annual General Meeting
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 1 3341 6152 7431 825--
Enterprise Value (EV)2 1 4391 6982 8081 9311 9131 888
P/E ratio 113x43,6x53,2x29,0x24,4x20,9x
Yield --0,39%0,73%0,95%1,11%
Capitalization / Revenue 4,29x5,34x7,55x4,37x3,85x3,42x
EV / Revenue 4,63x5,61x7,73x4,62x4,03x3,54x
EV / EBITDA 15,7x19,3x26,2x16,1x13,9x12,1x
Price to Book 10,8x9,80x12,1x6,55x5,38x4,47x
Nbr of stocks (in thousands) 20 00020 00019 99719 990--
Reference price (EUR) 66,780,713791,391,391,3
Announcement Date 04/06/202003/30/202103/11/2022---
1 CHF in Million
2 EUR in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 311303363418474533
EBITDA1 91,588,1107120137156
Operating profit (EBIT)1 57,851,166,775,588,9104
Operating Margin 18,6%16,9%18,4%18,1%18,7%19,4%
Pre-Tax Profit (EBT)1 13,639,9-71,084,5101
Net income1 11,937,151,561,172,686,3
Net margin 3,82%12,3%14,2%14,6%15,3%16,2%
EPS2 0,591,852,583,153,744,37
Dividend per Share2 --0,540,660,861,01
Announcement Date 04/06/202003/30/202103/11/2022---
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2
Net sales1 135168177186201221
EBITDA1 32,156,056,6-55,463,8
Operating profit (EBIT)1 13,337,838,128,633,240,6
Operating Margin 9,86%22,5%21,4%15,4%16,5%18,3%
Pre-Tax Profit (EBT) ------
Net income1 9,6827,429,721,828,034,5
Net margin 7,18%16,3%16,8%11,7%13,9%15,6%
EPS ------
Dividend per Share ------
Announcement Date 09/07/202003/30/202109/10/202103/11/2022--
1 EUR in Million
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 10683,365,310788,163,3
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,15x0,95x0,61x0,89x0,64x0,40x
Free Cash Flow1 0,8925,47,5732,541,551,5
ROE (Net Profit / Equities) 42,5%25,8%30,1%25,0%24,2%23,4%
Shareholders' equity1 27,9144171244301369
ROA (Net Profit / Asset) 11,6%8,68%12,6%11,6%12,4%13,0%
Assets1 102427409528588665
Book Value Per Share2 6,168,2411,313,917,020,4
Cash Flow per Share2 -2,982,704,304,965,80
Capex1 41,534,252,054,659,765,4
Capex / Sales 13,4%11,3%14,3%13,1%12,6%12,3%
Announcement Date 04/06/202003/30/202103/11/2022---
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Key data
Capitalization (CHF) 1 827 085 360
Capitalization (USD) 1 897 876 140
Net sales (EUR) 363 126 000
Net sales (USD) 377 705 430
Number of employees 1 341
Sales / Employee (EUR) 270 787
Sales / Employee (USD) 281 660
Free-Float 30,4%
Free-Float capitalization (CHF) 555 750 492
Free-Float capitalization (USD) 577 283 154
Avg. Exchange 20 sessions (EUR) 713 839
Avg. Exchange 20 sessions (USD) 742 499
Average Daily Capital Traded 0,04%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA